Evaluation of time-course changes of clinical symptoms in patients with inflammatory bowel diseases with serum zinc deficiency

Clinical meaning of serum zinc deficiency in patients with inflammatory bowel diseases - Clinical meaning of serum zinc deficiency in IBD patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039892

Enrollment

Registered

2020-05-11

Start date

2020-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis and Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ulcetative colitis or Crohn's disease

Exclusion criteria

Exclusion criteria: 1. Patients without informed consent 2. Inappropriate patients for this study determined by doctors

Design outcomes

Primary

Measure	Time frame
Changes of Visual Analogue Score (VAS) of fatigue after the zinc replacement therapy	—

Secondary

Measure	Time frame
1. Changes of VAS score of abnormality of taste 2. Cahnges of "Jikakushojo-Shirabe" score 3. Changes of CDAIand PMS 4. Clinical response and remission rates 5. Changes of hemoglobin titer 6. Changes of alkaline-phosphatase titer 7. Changes of another clinical symptoms 8. Safety profile of zinc replacement therapy	—

Countries

Japan

Contacts

Public ContactShingo kato

Saitama Medical Center, Saitama Medical University Department of Gastroenterology and Hepatology

skato@saitama-med.ac.jp049-228-3564

Outcome results